相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study
Seokuee Kim et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2020)
Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
Yiran Wang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets
Jun Gi Hwang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcer
Yu Kyung Cho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
In Vitro and In Vivo Rat Model Assessments of the Effects of Vonoprazan on the Pharmacokinetics of Venlafaxine
Feifei Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects
Jung Sunwoo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study
Kyung-Bok Son et al.
BMJ OPEN (2019)
Effectiveness and Safety of Clopidogrel Co-administered With Statins and Proton Pump Inhibitors: A Korean National Health Insurance Database Study
Mi-Sook Kim et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel
Mitsuhiro Nishihara et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2019)
Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker
Hideki Mori et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
Kwang Jae Lee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype
Takuma Kagami et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease
Masatsugu Okuyama et al.
DIGESTION (2017)
Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438)
Kazuyoshi Otake et al.
ADVANCES IN THERAPY (2016)
Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases
Nobuhiro Inatomi et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Sample Sizes for Designing Bioequivalence Studies for Highly Variable Drugs
Laszlo Endrenyi et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2016)
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Philip O. Katz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
The use of baseline covariates in crossover studies
Michael G. Kenward et al.
BIOSTATISTICS (2010)
Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers
Y. Y. Lau et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy
Monica Hermann et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors
TA Jacobson
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Clinical pharmacokinetics of atorvastatin
H Lennernas
CLINICAL PHARMACOKINETICS (2003)
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047
CJ Fichtenbaum et al.
AIDS (2002)
分享论文
